For more information or confidential assistance
Call 800-306-3180

Did Pradaxa Manufacturer Withhold Bleeding Data?

Pradaxa FDA warning
According to a new report, an investigation by the British Medical Journal suggests that manufacturer Boehringer Ingelheim withheld evidence of Pradaxa bleeding events from government regulators. Without access to the undisclosed drug risk information, the Federal Drug Administration (FDA) and foreign regulators approved the use... Read More

FDA Cautions About Pradaxa Stomach Bleed Risk

diane 35 blood clot risk
In an FDA drug safety communication published on May 13, the agency warned of an increased stomach bleeding risk with Pradaxa compared to its competitor, warfarin. Both anticoagulant medications are used to reduce the chance of stroke in patients with non-valvular atrial fibrillation, but recent... Read More

Pradaxa Lawsuits Name Researchers as Defendants

Pradaxa Lawsuits
As Pradaxa lawsuits continue to mount, some of the plaintiffs filing complaints are attempting to hold additional parties accountable for injuries related to the anticoagulant drug. Nearly all the plaintiffs filing complaints are naming Boehringer Ingelheim as the primary defendant. However, The Spectator reports that... Read More

Judge Identifies Pradaxa Bellwether Lawsuits

diane 35 blood clot risk
The litigation process for product liability multidistrict litigation (MDL) No. 2385 is moving steadily forward. U.S. District Judge Robert R. Herndon issued a Case Management Order on January 23, 2014, which identified the first four Pradaxa bleeding injury lawsuits to be heard in court. The... Read More